kabutan

StemCell Institute(7096) Summary

7096
TSE Growth
StemCell Institute
830
JPY
-10
(-1.19%)
Mar 13, 3:30 pm JST
5.20
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
840
Mar 13, 11:32 pm JST
Summary Chart Historical News Financial Result
PER
26.1
PBR
3.14
Yield
ー%
Margin Trading Ratio
12.69
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
845 JPY 5.30 USD
Previous Close Mar 12
840 JPY 5.28 USD
High Mar 13, 9:50 am
858 JPY 5.39 USD
Low Mar 13, 3:20 pm
830 JPY 5.20 USD
Volume
28,400
Trading Value
0.02B JPY 0.15M USD
VWAP
837.2 JPY 5.25 USD
Minimum Trading Value
83,000 JPY 520 USD
Market Cap
8.50B JPY 0.05B USD
Number of Trades
79
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
170
1-Year High Jul 16, 2025
5,341
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 71,300 276,000 3.87
Feb 27, 2026 48,400 277,200 5.73
Feb 20, 2026 20,600 271,500 13.18
Feb 13, 2026 22,000 283,300 12.88
Feb 6, 2026 23,900 284,800 11.92
Company Profile
StemCell Institute operates a cell bank business for regenerative medicine, focusing on the separation and storage of umbilical cord blood. It is part of the Nihon Trim Group.
Sector
Services
StemCell Institute develops a cell bank business for regenerative medicine and cell therapy. The company separates and stores cells derived from perinatal tissues such as umbilical cord blood and umbilical cords for future medical treatments. Umbilical cord blood contains hematopoietic stem cells and mesenchymal cells, and clinical research is progressing on regenerative medicine and cell therapy for pediatric central nervous system diseases and autism spectrum disorders. StemCell Institute has cell processing centers in Tokyo and Yokohama, and a cell storage center in Yokohama, with various certifications including a license for manufacturing specific cell products. In addition to umbilical cord blood storage, the company has also launched umbilical cord tissue storage services. StemCell Institute is also engaged in the development of regenerative medicine products and business development and investment in related fields.